CRVS
Price
$7.37
Change
+$0.09 (+1.24%)
Updated
Sep 30 closing price
Capitalization
548.8M
29 days until earnings call
IPSC
Price
$0.50
Change
-$0.00 (-0.00%)
Updated
Sep 30 closing price
Capitalization
43.02M
36 days until earnings call
Interact to see
Advertisement

CRVS vs IPSC

Header iconCRVS vs IPSC Comparison
Open Charts CRVS vs IPSCBanner chart's image
Corvus Pharmaceuticals
Price$7.37
Change+$0.09 (+1.24%)
Volume$1.54M
Capitalization548.8M
Century Therapeutics
Price$0.50
Change-$0.00 (-0.00%)
Volume$234.25K
Capitalization43.02M
CRVS vs IPSC Comparison Chart in %
Loading...
CRVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRVS vs. IPSC commentary
Oct 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVS is a Buy and IPSC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 01, 2025
Stock price -- (CRVS: $7.28 vs. IPSC: $0.50)
Brand notoriety: CRVS and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVS: 104% vs. IPSC: 53%
Market capitalization -- CRVS: $548.8M vs. IPSC: $43.02M
CRVS [@Biotechnology] is valued at $548.8M. IPSC’s [@Biotechnology] market capitalization is $43.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.41B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVS’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • CRVS’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, CRVS is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVS’s TA Score shows that 5 TA indicator(s) are bullish while IPSC’s TA Score has 5 bullish TA indicator(s).

  • CRVS’s TA Score: 5 bullish, 4 bearish.
  • IPSC’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than CRVS.

Price Growth

CRVS (@Biotechnology) experienced а +20.53% price change this week, while IPSC (@Biotechnology) price change was +4.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +12.63%, and the average quarterly price growth was +68.65%.

Reported Earning Dates

CRVS is expected to report earnings on Oct 30, 2025.

IPSC is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRVS($549M) has a higher market cap than IPSC($43M). CRVS YTD gains are higher at: 36.075 vs. IPSC (-50.535). IPSC has higher annual earnings (EBITDA): -6.16M vs. CRVS (-35.45M). IPSC has more cash in the bank: 156M vs. CRVS (74.4M). CRVS has less debt than IPSC: CRVS (1.08M) vs IPSC (51.5M). IPSC has higher revenues than CRVS: IPSC (114M) vs CRVS (0).
CRVSIPSCCRVS / IPSC
Capitalization549M43M1,277%
EBITDA-35.45M-6.16M576%
Gain YTD36.075-50.535-71%
P/E RatioN/AN/A-
Revenue0114M-
Total Cash74.4M156M48%
Total Debt1.08M51.5M2%
FUNDAMENTALS RATINGS
CRVS: Fundamental Ratings
CRVS
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRVSIPSC
RSI
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 29 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSNGX67.26N/A
N/A
JPMorgan Mid Cap Equity I
BMIAX7.61N/A
N/A
BNY Mellon Income Stock A
RBCRX12.37N/A
N/A
RBC China Equity R6
NWAEX18.48N/A
N/A
Nationwide BNY Mellon Dyn US Core Eagle
WHGOX12.71N/A
N/A
Westwood Income Opportunity Ultra

CRVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been loosely correlated with SYRE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVS jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
-1.49%
SYRE - CRVS
46%
Loosely correlated
+0.74%
RZLT - CRVS
42%
Loosely correlated
-0.54%
TERN - CRVS
41%
Loosely correlated
+1.96%
IPSC - CRVS
41%
Loosely correlated
-1.87%
KRRO - CRVS
37%
Loosely correlated
+5.26%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-1.87%
CRSP - IPSC
55%
Loosely correlated
+3.41%
CABA - IPSC
52%
Loosely correlated
+0.85%
ARWR - IPSC
51%
Loosely correlated
+2.99%
IMNM - IPSC
51%
Loosely correlated
-2.16%
FATE - IPSC
50%
Loosely correlated
N/A
More